Mirion Technologies (MIR) AI Stock Analysis

• Market Cap: $5.17B
• Dividend Yield: N/A
• Average Volume (3M): 2.97M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.48
• Revenue Growth: 7.25%
• EPS Growth: 87.34%
• Country: US
• Employees: 2,800
• Sector: Industrials
• Sector Strength: 94
• Industry: Industrial - Machinery
• EPS (TTM): 0.10
• Shares Outstanding: 225,554,630
• 10 Day Avg. Volume: 2,230,812
• 30 Day Avg. Volume: 2,973,681
• PEG Ratio: -0.13
• Price to Book (P/B): 3.01
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 55.61
• Enterprise Value/Market Cap: 1.01
• Enterprise Value/Revenue: 1.54
• Enterprise Value/Gross Profit: 11.97
• Enterprise Value/Ebitda: 13.58
• 1Y Price Target: $22.67
• Price Target Upside: 1.66% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3

• Rating: 70 Outperform
• Price Target: $24.00 ▲(7.62%Upside)

Mirion Technologies demonstrates strong financial growth and technical indicators suggest positive momentum. The recent corporate financing events enhance its financial stability. However, challenges in profitability and valuation, notably the negative P/E ratio, weigh on the score. The company's strategic initiatives and market opportunities position it well, but achieving consistent profitability remains crucial.

Positive Factors

Business Growth

MIR’s Nuclear & Safety business continues to have significant growth tailwinds that should be supportive of MIR’s targeted +6%-8% organic growth in the business with still meaningful margin expansion potential.

Market Position

Favorable demand drivers and MIR’s strong position within its end markets could be durable growth drivers.

Mergers and Acquisitions

Management noted reduced net leverage at 2.5x and indicated a 'very strong' M&A pipeline, viewing acquisition-oriented capital deployment as likely to accelerate.

Negative Factors

Market Demand

Nuclear power generation could continue to be viewed increasingly favorably, driving solid underlying demand for MIR’s commercial nuclear business.

Operational Challenges

An increased focus on operational execution and continuous improvement is contributing to ongoing margin expansion potential.

Strategic Focus

MIR Medical strategy seems to be maturing in Medical where increased focus on integrating software with hardware, continued emphasis on independent quality assurance, and greater focus on lean/value analysis and value engineering should drive continued improvements in MIR Medical’s performance.

Mirion Technologies Business Overview & Revenue Model

Company Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

How the Company Makes Money

Mirion Technologies generates revenue through the sale of its diverse range of radiation detection and monitoring products and services to multiple industries, including nuclear power plants, hospitals, military, and government agencies. A significant portion of its earnings comes from product sales, which include radiation monitoring equipment and nuclear measurement devices. The company also offers services like dosimetry, where it provides personal radiation monitoring and reporting services, contributing to a steady stream of recurring revenue. Additionally, Mirion leverages strategic partnerships and contracts with government and private entities to enhance its market reach and bolster its revenue streams.

Mirion Technologies Financial Statement Overview

Summary

Mirion Technologies demonstrates strong revenue growth and improved gross profit margins, along with significant debt reduction and positive cash flows. However, challenges remain in achieving consistent profitability, which tempers the score.

Income Statement

Mirion Technologies shows a consistent revenue growth trajectory, increasing from $322.1 million in 2021 to $870.2 million in the TTM, indicating strong market demand. Gross profit margin has improved to 50% in the TTM, suggesting effective cost management. However, the net profit margin remains negative, indicating ongoing challenges in achieving profitability. EBIT and EBITDA margins show signs of recovery, but further improvements are needed to ensure sustainable profitability.

Balance Sheet

The company's balance sheet displays improving financial health with a reduction in total debt from $1,698 million in 2020 to $33.6 million in the TTM. The debt-to-equity ratio has significantly improved, reflecting reduced leverage. Stockholders' equity has turned positive, indicating a stronger equity base. However, the equity ratio remains moderate, and further strengthening of the equity position is recommended.

Cash Flow

Mirion Technologies shows strong cash flow management with positive operating and free cash flows in the TTM. The operating cash flow to net income ratio is robust, indicating effective cash generation relative to earnings. Free cash flow has grown substantially, highlighting efficient capital expenditure management. These factors suggest good liquidity and operational efficiency.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	860.80M	800.90M	717.80M	322.10M	478.20M
Gross Profit	399.70M	356.40M	317.20M	81.10M	197.00M
EBITDA	174.40M	114.30M	-90.80M	-19.20M	22.88M
Net Income	-36.10M	-96.90M	-324.80M	-127.90M	-1.04M
Balance Sheet
Total Assets	2.64B	2.72B	2.74B	3.12B	751.32M
Cash, Cash Equivalents and Short-Term Investments	181.10M	134.10M	77.80M	84.00M	383.25K
Total Debt	719.90M	721.00M	849.60M	860.60M	1.70B
Total Liabilities	1.08B	1.17B	1.27B	1.33B	27.59M
Stockholders Equity	1.56B	1.48B	-408.50M	1.69B	723.72M
Cash Flow
Free Cash Flow	50.30M	58.10M	5.20M	-16.70M	-20.85M
Operating Cash Flow	99.10M	95.20M	39.40M	900.00K	-945.35K
Investing Cash Flow	-43.70M	-64.70M	-40.80M	-2.20B	-75.60M
Financing Cash Flow	-3.30M	22.60M	-7.00M	1.54B	751.39M

Mirion Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.30
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MIR, the sentiment is Positive. The current price of 22.3 is above the 20-day moving average (MA) of 21.13, above the 50-day MA of 20.16, and above the 200-day MA of 16.75, indicating a bullish trend. The MACD of 0.55 indicates Negative momentum. The RSI at 66.52 is Neutral, neither overbought nor oversold. The STOCH value of 80.05 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MIR.

Mirion Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NPO	75 Outperform	$4.45B	52.71	5.90%	0.58%	2.92%	―
MWA	75 Outperform	$3.94B	27.48	17.68%	1.06%	10.96%	43.44%
FELE	73 Outperform	$4.26B	24.41	14.11%	1.10%	-1.26%	-4.84%
KAI	73 Outperform	$4.05B	36.51	13.38%	0.38%	6.83%	-1.84%
Sector *	71 Outperform	¥266.83B	14.00	8.47%	2.88%	6.35%	13.13%
MIR	70 Outperform	$5.17B	―	-0.68%	―	7.25%	87.34%
CXT	66 Neutral	$3.41B	20.47	16.23%	1.11%	9.28%	-8.45%

Mirion Technologies Corporate Events

Mirion Technologies Secures New $450 Million Loan Tranche

On June 5, 2025, Mirion Technologies entered into Amendment No. 5 to its Credit Agreement, introducing a new $450 million tranche of term loans maturing in 2032. This amendment allows for refinancing of existing loans and offers favorable terms such as reduced interest rates contingent on achieving certain credit ratings, alongside increased flexibility for financial operations, potentially enhancing the company’s financial stability and operational capacity.

The most recent analyst rating on (MIR) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Mirion Technologies Initiates $450M Refinancing Process

On May 29, 2025, Mirion Technologies initiated a refinancing process involving a $450 million tranche of replacement term loans. These loans are expected to mature in 2032 and will be used to refinance existing term loans under a previous credit agreement. The refinancing is anticipated to close in the second quarter of 2025, although its completion is subject to certain conditions.

The most recent analyst rating on (MIR) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Mirion Technologies Completes $400M Convertible Notes Offering

On May 23, 2025, Mirion Technologies completed a private offering of $400 million in 0.25% Convertible Senior Notes due 2030, which was increased from the initially planned $300 million. The proceeds will be used for capped call transactions, repaying term loans, repurchasing shares, and general corporate purposes. The notes are convertible under specific conditions and include capped call transactions to mitigate potential stock dilution. This strategic financial move aims to strengthen Mirion’s capital structure and enhance its market positioning.

The most recent analyst rating on (MIR) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Mirion Technologies Announces $300M Convertible Notes Offering

On May 20, 2025, Mirion Technologies announced its plan to offer $300 million in Convertible Senior Notes due 2030 in a private placement to qualified institutional buyers. The proceeds from this offering will be used to refinance existing loans, repurchase shares, and for general corporate purposes, potentially impacting the company’s market positioning by providing greater financial flexibility.

The most recent analyst rating on (MIR) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.

Mirion Technologies Elects Directors at Annual Meeting

On May 15, 2025, Mirion Technologies held its 2025 Annual Meeting of Stockholders where eight directors were elected to the Board for a one-year term. Additionally, the stockholders ratified Deloitte & Touche, LLP as the independent public accounting firm for the fiscal year ending December 31, 2025, and approved the 2024 compensation for the company’s executive officers.

The most recent analyst rating on (MIR) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Mirion Technologies stock, see the MIR Stock Forecast page.